By Jessica Pyhtila, PharmD, BCGP, BCPS The FDA recently approved Dartisla ODT, an orally disintegrating tablet form of the antimuscarinic agent glycopyrrolate. Originally approved in 1961, glycopyrrolate is currently available in tablet and solution forms for oral use. In addition, an inhaled version of glycopyrrolate is available to help treat…